HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Magnus Essand Selected Research

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)

1/2020TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment.
1/2017The cancer-immunity cycle as rational design for synthetic cancer drugs: Novel DC vaccines and CAR T-cells.
1/2014Systemic treatment with CAR-engineered T cells against PSCA delays subcutaneous tumor growth and prolongs survival of mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Magnus Essand Research Topics

Disease

52Neoplasms (Cancer)
12/2023 - 05/2003
16Prostatic Neoplasms (Prostate Cancer)
01/2022 - 08/2003
8Glioblastoma (Glioblastoma Multiforme)
12/2023 - 11/2015
7Glioma (Gliomas)
12/2023 - 12/2015
6Adenocarcinoma
01/2022 - 08/2003
5Neoplasm Metastasis (Metastasis)
01/2022 - 04/2007
4Brain Neoplasms (Brain Tumor)
12/2023 - 12/2016
4Neuroblastoma
01/2022 - 12/2011
4Breast Neoplasms (Breast Cancer)
01/2016 - 10/2004
4Carcinoid Tumor (Carcinoid)
01/2010 - 01/2005
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2020 - 01/2014
3Infections
01/2018 - 02/2016
3Neuroendocrine Tumors (Neuroendocrine Tumor)
11/2013 - 01/2010
3Urinary Bladder Neoplasms (Bladder Cancer)
01/2008 - 01/2005
2Lymphoma (Lymphomas)
10/2023 - 12/2018
2B-Cell Lymphoma (Lymphoma, B Cell)
12/2022 - 12/2016
2Carcinoma (Carcinomatosis)
01/2022 - 01/2005
2Tertiary Lymphoid Structures
01/2021 - 01/2021
2Inflammation (Inflammations)
04/2020 - 01/2018
2Melanoma (Melanoma, Malignant)
01/2020 - 01/2018
2B-Cell Leukemia (Leukemia, B Cell)
12/2016 - 01/2016
2Hypoxia (Hypoxemia)
01/2013 - 03/2011
1Alzheimer Disease (Alzheimer's Disease)
06/2022
1Parkinson Disease (Parkinson's Disease)
04/2020
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2020
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020
1Adenoviridae Infections (Adenovirus Infections)
01/2018
1Encephalitis (Encephalitis, Rasmussen)
03/2017
1Astrocytoma (Pilocytic Astrocytoma)
12/2015

Drug/Important Bio-Agent (IBA)

15AntigensIBA
01/2023 - 05/2003
15Proteins (Proteins, Gene)FDA Link
01/2022 - 08/2003
11Chimeric Antigen ReceptorsIBA
10/2023 - 01/2014
7Peptides (Polypeptides)IBA
06/2022 - 10/2004
7TARPIBA
01/2020 - 08/2003
5EpitopesIBA
01/2018 - 10/2004
4Therapeutic UsesIBA
01/2018 - 01/2005
4Chromogranin AIBA
01/2017 - 04/2007
4CytokinesIBA
12/2015 - 01/2008
4CD40 Ligand (CD40L)IBA
04/2014 - 06/2004
4HLA-A*02:01 antigenIBA
01/2009 - 10/2004
3RNA (Ribonucleic Acid)IBA
10/2023 - 01/2020
3Immune Checkpoint InhibitorsIBA
01/2021 - 01/2017
3InterferonsIBA
01/2020 - 01/2009
3T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2018 - 09/2012
2Complement System Proteins (Complement)IBA
06/2023 - 03/2007
2Antiviral Agents (Antivirals)IBA
06/2021 - 02/2019
2DNA (Deoxyribonucleic Acid)IBA
01/2021 - 08/2013
2AntibodiesIBA
01/2021 - 01/2017
2EnzymesIBA
01/2020 - 12/2016
2Biomarkers (Surrogate Marker)IBA
01/2019 - 02/2009
2LigandsIBA
01/2018 - 02/2009
2Viral DNAIBA
01/2018 - 02/2016
2Hormones (Hormone)IBA
06/2017 - 08/2004
2MicroRNAs (MicroRNA)IBA
03/2017 - 01/2010
2Cell-Penetrating PeptidesIBA
01/2017 - 08/2013
2VaccinesIBA
01/2017 - 05/2003
2Interleukin-12 (IL 12)IBA
05/2012 - 06/2004
2Serotonin (5 Hydroxytryptamine)IBA
02/2009 - 01/2005
2gamma-delta T-Cell Antigen Receptors (T-Cell Receptor delta-Chain)IBA
08/2004 - 08/2003
1RNA IsoformsIBA
11/2022
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
06/2022
1Presenilin-1IBA
06/2022
1Amyloid (Amyloid Fibrils)IBA
06/2022
1Liposomes (Liposome)IBA
01/2022
1Virulence Factors (Pathogenicity Factors)IBA
01/2022
1Interferon Type IIBA
06/2021
1Hyaluronic Acid (Hyaluronan)IBA
01/2021
1Neoplasm Antigens (Tumor Antigens)IBA
01/2021
1alpha-SynucleinIBA
04/2020
1Protein AggregatesIBA
04/2020
1epacadostatIBA
01/2020
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2018
1fludarabineIBA
12/2018
1IntegrinsIBA
01/2018
1RNA Splicing FactorsIBA
01/2018
1gp100 Melanoma AntigenIBA
01/2018
1Fibronectins (Fibronectin)IBA
01/2018
1teleocalcinIBA
01/2018
1Cancer VaccinesIBA
01/2018
1histidine-rich proteinsIBA
01/2018
1heparanaseIBA
12/2016
1Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA
12/2016
1tyrosine receptor (receptor, tyrosine)IBA
12/2016
1SugarsIBA
12/2016
1Phosphotransferases (Kinase)IBA
12/2016
1HLA-A2 Antigen (HLA A2 Antigen)IBA
01/2016
1CrizotinibIBA
12/2015
1Heparin (Liquaemin)FDA LinkGeneric
12/2015
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2015
1pleiotrophin (HARP)IBA
12/2015
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
12/2015

Therapy/Procedure

34Therapeutics
12/2023 - 06/2004
25Immunotherapy
12/2023 - 10/2004
2Drug Therapy (Chemotherapy)
12/2018 - 01/2013
2Cell- and Tissue-Based Therapy (Cell Therapy)
01/2017 - 01/2016
2Transplantation
01/2015 - 01/2013
1Phototherapy (Light Therapy)
12/2023
1Intravenous Administration
01/2022
1Oncolytic Virotherapy
06/2021
1Intravenous Injections
03/2017